Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes - Trial NCT06282055
Access comprehensive clinical trial information for NCT06282055 through Pure Global AI's free database. This phase not specified trial is sponsored by DCB Research AG and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 250 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
DCB Research AG
Timeline & Enrollment
N/A
Mar 01, 2024
Mar 01, 2026
Primary Outcome
Identify different trajectories of insulin sensitivity throughout the menstrual cycle
Summary
Standardized longitudinal data collection of diabetes management relevant factors in women
 with T1D (insulin requirements (insulin pump or smart pen data), glucose variability (CGM
 data), nutritional information, and menstrual cycle information (cycle tracking app, LH
 tests, and premenstrual symptoms)) to identify categories of cycle trajectories.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06282055
Non-Device Trial